Groupama Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.1M Buy
283,868
+14,997
+6% +$4.15M 0.78% 38
2026
Q1
$79.4M Buy
268,871
+37,526
+16% +$11.1M 1.16% 27
2025
Q4
$63.2M Sell
231,345
-5,315
-2% -$1.44M 0.93% 27
2025
Q3
$63.9M Buy
236,660
+8,847
+4% +$2.41M 0.94% 27
2025
Q2
$62.6M Buy
227,813
+84,694
+59% +$23M 1.04% 23
2025
Q1
$37.5M Buy
143,119
+7,658
+6% +$1.89M 0.75% 34
2024
Q4
$31.4M Buy
135,461
+98,219
+264% +$22.6M 0.64% 41
2024
Q3
$6.6M Sell
37,242
-4,547
-11% -$941K 0.17% 90
2024
Q2
$8.22M Buy
41,789
+6,132
+17% +$1.27M 0.11% 104
2024
Q1
$8.97M Sell
35,657
-84,389
-70% -$17.7M 0.16% 108
2023
Q4
$12.9M Buy
+120,046
New +$25.6M 0.34% 56

Other funds holding CME

Groupama Asset Management's CME Position: Q2 2026 in Review

Groupama Asset Management increased its CME Group (CME) stake by 5.6% in Q2 2026, buying an estimated $4.15M and bringing the position to 283,868 shares worth $62.1M. The position accounts for 0.78% of the portfolio, ranked #38.

Groupama Asset Management first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $79.4M in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Groupama Asset Management held 283,868 shares of CME Group worth $62.1M as of Q2 2026.
  • Groupama Asset Management bought 14,997 CME Group shares in Q2 2026, an estimated $4.15M.
  • CME Group made up 0.78% of Groupama Asset Management's portfolio in Q2 2026, its #38 holding.
  • Groupama Asset Management first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Groupama Asset Management's CME Group position peaked at $79.4M in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.